company background image
1720 logo

Standard Chemical & Pharmaceutical TWSE:1720 Stock Report

Last Price

NT$70.90

Market Cap

NT$12.7b

7D

-0.4%

1Y

1.7%

Updated

14 Jun, 2024

Data

Company Financials +

Standard Chemical & Pharmaceutical Co. Ltd.

TWSE:1720 Stock Report

Market Cap: NT$12.7b

1720 Stock Overview

Standard Chemical & Pharmaceutical Co. Ltd.

1720 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Standard Chemical & Pharmaceutical Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Standard Chemical & Pharmaceutical
Historical stock prices
Current Share PriceNT$70.90
52 Week HighNT$77.70
52 Week LowNT$58.10
Beta0.14
1 Month Change4.26%
3 Month Change9.25%
1 Year Change1.72%
3 Year Change79.04%
5 Year Change113.88%
Change since IPO226.62%

Recent News & Updates

Recent updates

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13
If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Mar 14
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Mar 01
Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Feb 16
Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Feb 03
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19
Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04
Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22
Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26
Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Shareholder Returns

1720TW PharmaceuticalsTW Market
7D-0.4%0.5%1.9%
1Y1.7%5.9%27.4%

Return vs Industry: 1720 underperformed the TW Pharmaceuticals industry which returned 5.9% over the past year.

Return vs Market: 1720 underperformed the TW Market which returned 27.4% over the past year.

Price Volatility

Is 1720's price volatile compared to industry and market?
1720 volatility
1720 Average Weekly Movement2.7%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 1720 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1720's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1967n/aTzu-Ting Fanwww.standard.com.tw

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients.

Standard Chemical & Pharmaceutical Co. Ltd. Fundamentals Summary

How do Standard Chemical & Pharmaceutical's earnings and revenue compare to its market cap?
1720 fundamental statistics
Market capNT$12.65b
Earnings (TTM)NT$876.61m
Revenue (TTM)NT$6.36b

14.5x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1720 income statement (TTM)
RevenueNT$6.36b
Cost of RevenueNT$3.60b
Gross ProfitNT$2.76b
Other ExpensesNT$1.88b
EarningsNT$876.61m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.91
Gross Margin43.38%
Net Profit Margin13.78%
Debt/Equity Ratio11.6%

How did 1720 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

55%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.